Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Frédéric Debellut, Clint Pecenka, William P. Hausdorff & Andrew Clark. (2022) Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Upayan Patra, Urbi Mukhopadhyay, Arpita Mukherjee, Shanta Dutta & Mamta Chawla-Sarkar. (2021) Treading a HOSTile path: Mapping the dynamic landscape of host cell–rotavirus interactions to explore novel host-directed curative dimensions. Virulence 12:1, pages 1022-1062.
Read now
Read now
Adriana Guzman-Holst, Eduardo Ortega-Barria, Ángel Alexis Flores, Roberto Carreño-Manjarrez, Dagna Constenla & Maria Yolanda Cervantes-Apolinar. (2021) 15-year experience with rotavirus vaccination in Mexico: a systematic literature review. Human Vaccines & Immunotherapeutics 17:10, pages 3623-3637.
Read now
Read now
Debasish Saha, Martin O.C. Ota, Priya Pereira, Philippe Buchy & Selim Badur. (2021) Rotavirus vaccines performance: dynamic interdependence of host, pathogen and environment. Expert Review of Vaccines 20:8, pages 945-957.
Read now
Read now
Benjamin Lee. (2021) Update on rotavirus vaccine underperformance in low- to middle-income countries and next-generation vaccines. Human Vaccines & Immunotherapeutics 17:6, pages 1787-1802.
Read now
Read now
Yuxiao Wang, Jingxin Li, Pei Liu & Fengcai Zhu. (2021) The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review. Human Vaccines & Immunotherapeutics 17:3, pages 880-896.
Read now
Read now
Benjamin D. Hallowell, Jacqueline Tate & Umesh Parashar. (2020) An overview of rotavirus vaccination programs in developing countries. Expert Review of Vaccines 19:6, pages 529-537.
Read now
Read now
Dani Cohen & Khitam Muhsen. (2019) Vaccines for enteric diseases. Human Vaccines & Immunotherapeutics 15:6, pages 1205-1214.
Read now
Read now
Articles from other publishers (35)
Darby Gilfillan, Allison C. Vilander, Meichen Pan, Yong Jun Goh, Sarah O’Flaherty, Ningguo Feng, Bridget E. Fox, Callie Lang, Harry B. Greenberg, Zaid Abdo, Rodolphe Barrangou & Gregg A. Dean. (2023) Lactobacillus acidophilus Expressing Murine Rotavirus VP8 and Mucosal Adjuvants Induce Virus-Specific Immune Responses. Vaccines 11:12, pages 1774.
Crossref
Crossref
Robyn-Lee Potgieter, Peter N. Mwangi, Milton T. Mogotsi, Jeannine Uwimana, Leon Mutesa, Narcisse Muganga, Didier Murenzi, Lisine Tusiyenge, Mapaseka L. Seheri, A. Duncan Steele, Jason M. Mwenda & Martin M. Nyaga. (2023) Genomic Analysis of Rwandan G9P[8] Rotavirus Strains Pre- and Post-RotaTeq® Vaccine Reveals Significant Distinct Sub-Clustering in a Post-Vaccination Cohort. Viruses 15:12, pages 2321.
Crossref
Crossref
Pritu Dhalaria, Sanjay Kapur, Ajeet Kumar Singh, Ajay Verma, Pretty Priyadarshini & Gunjan Taneja. (2023) Potential impact of rotavirus vaccination on reduction of childhood diarrheal disease in India: An analysis of National Family Health Survey-5. Vaccine: X 14, pages 100319.
Crossref
Crossref
Tatiana A. Sashina, E. I. Velikzhanina, O. V. Morozova, N. V. Epifanova & N. A. Novikova. (2023) Detection and full-genotype determination of rare and reassortant rotavirus A strains in Nizhny Novgorod in the European part of Russia. Archives of Virology 168:8.
Crossref
Crossref
Shireen Qassim Bham, Farhan Saeed, Umer Hayat Ahmed Sharif, Nighat Aijaz & Muhammad Faisal Rahim. (2023) Impact of Breast Feeding On Diarrhea and Pneumonia Among Vaccinated Children: Single Center Study. Pakistan Journal of Health Sciences, pages 95-99.
Crossref
Crossref
Inacio Mandomando, Augusto MessaJr.Jr., Joseph Nsiari-Muzeyi Biey, Gilson Paluku, Mutale Mumba & Jason M. Mwenda. (2023) Lessons Learned and Future Perspectives for Rotavirus Vaccines Switch in the World Health Organization, Regional Office for Africa. Vaccines 11:4, pages 788.
Crossref
Crossref
Alexandre C. Linhares & Maria Cleonice A. Justino. 2020. Viral Infections of Humans. Viral Infections of Humans
1
74
.
Andrej Steyer, Dušanka Mičetić-Turk & Sabina Fijan. (2022) The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature. Microorganisms 10:12, pages 2392.
Crossref
Crossref
Charles N. Agoti, Martin D. Curran, Nickson Murunga, Moses Ngari, Esther Muthumbi, Arnold W. Lambisia, Simon D. W. Frost, Barbara A. Blacklaws, D. James Nokes & Lydia N. Drumright. (2022) Differences in epidemiology of enteropathogens in children pre- and post-rotavirus vaccine introduction in Kilifi, coastal Kenya. Gut Pathogens 14:1.
Crossref
Crossref
Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Crossref
Ernest O. Asare, Mohammad A. Al-Mamun, Monira Sarmin, A. S. G. Faruque, Tahmeed Ahmed & Virginia E. Pitzer. (2022) The influence of demographic and meteorological factors on temporal patterns of rotavirus infection in Dhaka, Bangladesh. Proceedings of the Royal Society B: Biological Sciences 289:1976.
Crossref
Crossref
Anvar Nazurdinov, Zafarjon Azizov, Manija Mullojonova, Umeda Sadykova, Liudmila Mosina, Simarjit Singh, Sudoba Suleymonova, Farida Tishkova, Dovile Videbaek, Margaret M. Cortese, Danni S. Daniels & Rachel M. Burke. (2022) Impact and effectiveness of monovalent rotavirus vaccine in Tajik children. Vaccine 40:26, pages 3705-3712.
Crossref
Crossref
Floriana Bonura, Leonardo Mangiaracina, Chiara Filizzolo, Celestino Bonura, Vito Martella, Max Ciarlet, Giovanni M. Giammanco & Simona De Grazia. (2022) Impact of Vaccination on Rotavirus Genotype Diversity: A Nearly Two-Decade-Long Epidemiological Study before and after Rotavirus Vaccine Introduction in Sicily, Italy. Pathogens 11:4, pages 424.
Crossref
Crossref
Tintu Varghese, Gagandeep Kang & Andrew Duncan Steele. (2022) Understanding Rotavirus Vaccine Efficacy and Effectiveness in Countries with High Child Mortality. Vaccines 10:3, pages 346.
Crossref
Crossref
William P. Hausdorff, Jessica Price, Frédéric Debellut, Jessica Mooney, Andrew A. Torkelson, Khatuna Giorgadze & Clint Pecenka. (2022) Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines. Vaccines 10:2, pages 149.
Crossref
Crossref
Luis V. Monteagudo, Alfredo A. Benito, Sofía Lázaro-Gaspar, José L. Arnal, Desirée Martin-Jurado, Rut Menjon & Joaquín Quílez. (2022) Occurrence of Rotavirus A Genotypes and Other Enteric Pathogens in Diarrheic Suckling Piglets from Spanish Swine Farms. Animals 12:3, pages 251.
Crossref
Crossref
Alexandre C. Linhares & Maria Cleonice A. Justino. 2020. Viral Infections of Humans. Viral Infections of Humans
1
74
.
Neil C. Dalvie, Joseph R. Brady, Laura E. Crowell, Mary Kate Tracey, Andrew M. Biedermann, Kawaljit Kaur, John M. Hickey, D. Lee KristensenIIII, Alexandra D. Bonnyman, Sergio A. Rodriguez-Aponte, Charles A. Whittaker, Marina Bok, Celina Vega, Tarit K. Mukhopadhyay, Sangeeta B. Joshi, David B. Volkin, Viviana Parreño, Kerry R. Love & J. Christopher Love. (2021) Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus. Microbial Cell Factories 20:1.
Crossref
Crossref
Natsuki Kurokawa, Michelle K. Robinson, Catherine Bernard, Yutaka Kawaguchi, Yoshito Koujin, Anthonet Koen, Shabir Madhi, Thomas M. Polasek, Monica McNeal, Michèle Dargis, Manon M.-J. Couture, Sonia Trépanier, Bruce D. Forrest & Naohisa Tsutsui. (2021) Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants. Vaccine 39:39, pages 5513-5523.
Crossref
Crossref
Sheila Isanaka, Céline Langendorf, Monica Malone McNeal, Nicole Meyer, Brian Plikaytis, Souna Garba, Nathan Sayinzoga-Makombe, Issaka Soumana, Ousmane Guindo, Rockyiath Makarimi, Marie Francoise Scherrer, Eric Adehossi, Iza Ciglenecki & Rebecca F. Grais. (2021) Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial. PLOS Medicine 18:7, pages e1003655.
Crossref
Crossref
Kadri Kõivumägi, Hiie Soeorg, Karolin Toompere, Eveli Kallas, Ene-Ly Jõegeda, Evely Lass, Kristi Huik & Irja Lutsar. (2021) Rotavirus Strain Surveillance in Estonia After Introduction of Rotavirus Universal Mass Vaccination. Pediatric Infectious Disease Journal 40:5, pages 489-494.
Crossref
Crossref
Ahd Hamidi, Femke Hoeksema, Pim Velthof, Angelique Lemckert, Gert Gillissen, Alfred Luitjens, Julie E. Bines, Swathi R. Pullagurla, Prashant Kumar, David B. Volkin, Sangeeta B. Joshi, Menzo Havenga, Wilfried A.M. Bakker & Christopher Yallop. (2021) Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine. Vaccine 39:15, pages 2048-2059.
Crossref
Crossref
Xiang Li, Christinah Mukandavire, Zulma M Cucunubá, Susy Echeverria Londono, Kaja Abbas, Hannah E Clapham, Mark Jit, Hope L Johnson, Timos Papadopoulos, Emilia Vynnycky, Marc Brisson, Emily D Carter, Andrew Clark, Margaret J de Villiers, Kirsten Eilertson, Matthew J Ferrari, Ivane Gamkrelidze, Katy A M Gaythorpe, Nicholas C Grassly, Timothy B Hallett, Wes Hinsley, Michael L Jackson, Kévin Jean, Andromachi Karachaliou, Petra Klepac, Justin Lessler, Xi Li, Sean M Moore, Shevanthi Nayagam, Duy Manh Nguyen, Homie Razavi, Devin Razavi-Shearer, Stephen Resch, Colin Sanderson, Steven Sweet, Stephen Sy, Yvonne Tam, Hira Tanvir, Quan Minh Tran, Caroline L Trotter, Shaun Truelove, Kevin van Zandvoort, Stéphane Verguet, Neff Walker, Amy Winter, Kim Woodruff, Neil M Ferguson & Tini Garske. (2021) Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. The Lancet 397:10272, pages 398-408.
Crossref
Crossref
Cynthia Bonville & Joseph Domachowske. 2021. Vaccines. Vaccines
313
322
.
Mike J. Mwanga, Betty E. Owor, John B. Ochieng, Mwanajuma H. Ngama, Billy Ogwel, Clayton Onyango, Jane Juma, Regina Njeru, Elijah Gicheru, Grieven P. Otieno, Sammy Khagayi, Charles N. Agoti, Godfrey M. Bigogo, Richard Omore, O. Yaw Addo, Seheri Mapaseka, Jacqueline E. Tate, Umesh D. Parashar, Elizabeth Hunsperger, Jennifer R. Verani, Robert F. Breiman & D. James Nokes. (2020) Rotavirus group A genotype circulation patterns across Kenya before and after nationwide vaccine introduction, 2010–2018. BMC Infectious Diseases 20:1.
Crossref
Crossref
Sheng-Chieh Lin, Ka-Wai Tam, Jean Yu-Chun Yen, Meng-Che Lu, Elaine Ying-Fang Chen, Yung-Ting Kuo, Wen-Chuan Lin, Shu-Huey Chen, El-Wui Loh & Shih-Yen Chen. (2020) The impact of shared decision making with patient decision aids on the rotavirus vaccination rate in children: A randomized controlled trial. Preventive Medicine 141, pages 106244.
Crossref
Crossref
Mike J. Mwanga, Jennifer R. Verani, Richard Omore, Jacqueline E. Tate, Umesh D. Parashar, Nickson Murunga, Elijah Gicheru, Robert F. Breiman, D. James Nokes & Charles N. Agoti. (2020) Multiple Introductions and Predominance of Rotavirus Group A Genotype G3P[8] in Kilifi, Coastal Kenya, 4 Years after Nationwide Vaccine Introduction. Pathogens 9:12, pages 981.
Crossref
Crossref
Khitam Muhsen, Samba O. Sow, Milagritos D. Tapia, Fadima C. Haidara, Mardi Reymann, Valeria Asato, Wilbur H. Chen, Marcela F. Pasetti & Myron M. Levine. (2020) Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults. Scientific Reports 10:1.
Crossref
Crossref
Jaime MacDonald, Michelle J. Groome, Janet Mans & Nicola Page. (2020) FUT2 Secretor Status Influences Susceptibility to VP4 Strain-Specific Rotavirus Infections in South African Children. Pathogens 9:10, pages 795.
Crossref
Crossref
Michelle J Groome, Lee Fairlie, Julie Morrison, Alan Fix, Anthonet Koen, Maysseb Masenya, Lisa Jose, Shabir A Madhi, Nicola Page, Monica McNeal, Len Dally, Iksung Cho, Maureen Power, Jorge Flores & Stanley Cryz. (2020) Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases 20:7, pages 851-863.
Crossref
Crossref
A Duncan Steele & Michelle J Groome. (2020) Measuring Rotavirus Vaccine Impact in Sub-Saharan Africa. Clinical Infectious Diseases 70:11, pages 2314-2316.
Crossref
Crossref
Sumit Sharma, Marie Hagbom, Lennart Svensson & Johan Nordgren. (2020) The Impact of Human Genetic Polymorphisms on Rotavirus Susceptibility, Epidemiology, and Vaccine Take. Viruses 12:3, pages 324.
Crossref
Crossref
T. O. C. Faleye, U. E. George, C. Simsek, O. A. Arowolo, O. M. Adewumi, J. Matthijnssens & J. A. Adeniji. (2020) Reference Human Rotavirus A Genome Sequence from a Previously Vaccinated Child with Diarrhea in Nigeria. Microbiology Resource Announcements 9:5.
Crossref
Crossref
Sarah E. Blutt & Mary K. Estes. (2019) Gut Bacterial Bouncers: Keeping Viral Pathogens out of the Epithelium. Cell Host & Microbe 26:5, pages 569-570.
Crossref
Crossref
Baoming Jiang, Manish Patel & Roger I. Glass. (2019) Polio endgame: Lessons for the global rotavirus vaccination program. Vaccine 37:23, pages 3040-3049.
Crossref
Crossref